山东大学耳鼻喉眼学报 ›› 2020, Vol. 34 ›› Issue (3): 134-140.doi: 10.6040/j.issn.1673-3770.0.2019.605

• 论著 • 上一篇    

角膜再移植原因与植片失活的危险因素分析

郝文培1,2, 翟华蕾2, 孙晓彤2, 张雅妮3, 朱艳辉4, 孔倩倩2, 程钧2, 张婷2   

  1. 山东省医学科学院)/山东省眼科研究所/山东省眼科学重点实验室-省部共建国家重点实验室培育基地/青岛眼科医院, 山东 青岛 266071;
    3. 青岛大学, 山东 青岛 266071;
    4. 张家口市宣化区眼科医院, 河北 张家口 075100
  • 发布日期:2020-06-29
  • 通讯作者: 翟华蕾. E-mail:zhaihualei0001@126.com
  • 基金资助:
    国家自然科学基金青年基金(81500703)

Etiology of repeat keratoplasty and risk factors for failure of corneal grafts

HAO Wenpei1,2, ZHAI Hualei2, SUN Xiaotong2, ZHANG Yani3, ZHU Yanhui4, KONG Qianqian2, CHENG Jun2, ZHANG Ting2   

  1. 1. School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250022, Shandong, China;
    2. Qingdao Eye Hospital, State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Shandong Eye Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Qingdao 266071, Shandong, China;
    3. Qingdao University, Qingdao 266071, Shandong, China;
    4. Xuanhua District Eye Hospital of Zhangjiakou, Zhangjiakou 075100, Hebei, China
  • Published:2020-06-29

PDF (PC)

319

摘要： 目的 分析再次角膜移植的原因及影响角膜植片存活的危险因素。 方法 收集2010年1月至2018年12月于青岛眼科医院行角膜移植患者2060例资料,回顾性分析再次角膜移植的原因、首次角膜移植的原发病、既往及再次角膜移植的手术方式及术后并发症等资料。 结果 其中228例为再次角膜移植术(11.07%)。204例患者(207眼)接受再次角膜移植,其中189眼接受1次再次角膜移植,15眼接受2次再次角膜移植,3眼接受3次再次角膜移植,男性137例,女性67例,接受再次移植时的年龄为11~81岁,平均(49.93±14.32)岁。再次角膜移植的主要原因为角膜植片溃疡(60例,26.32%)、角膜植片内皮功能失代偿(58例,25.44%)、原发病复发(41例,17.98%)及角膜移植片混浊(32例,14.04%)。再次角膜移植的原发病主要为化脓性角膜炎(69眼,33.33%)、单纯疱疹病毒性角膜炎(32眼,15.46%)、角膜烧伤(22眼,10.63%)与角膜营养不良和变性(21眼,10.14%)。202例再次角膜移植的术式为穿透性角膜移植术(88.60%),26例再次角膜移植的术式为板层角膜移植术(11.40%),内皮移植术0例。再次角膜移植术式与既往角膜移植术式之间存在相关性(连续性校正χ2=43.365,P<0.01),既往手术方式影响再次角膜移植的手术方式。Cox多因素回归分析感染性原发病(P=0.005)、角膜植片直径>8.75 mm(P=0.040)、继发青光眼(P=0.027)以及角膜植片免疫排斥(P=0.047)是穿透性角膜移植失败的危险因素;感染性原发病(P=0.011)、角膜植片直径>8.75 mm(P=0.016)是前板层角膜移植失败的危险因素。 结论 再次角膜移植的主要原因为角膜植片溃疡,其次为角膜植片内皮功能失代偿,再次为原发病复发。再次角膜移植的原发病以化脓性角膜炎最多见,其次为单纯疱疹病毒性角膜炎,再次为角膜烧伤。既往手术方式影响再次角膜移植的手术方式。感染性原发病、角膜植片直径>8.75 mm、继发青光眼及发生免疫排斥是影响穿透性角膜移植术后植片存活的危险因素。感染性原发病和角膜植片直径>8.75 mm是影响前板层角膜移植术后植片存活的危险因素。

关键词: 再次角膜移植, 病因, 植片存活, 危险因素

Abstract: Objective This study aimed to analyze the causes of repeat keratoplasty and the risk factors for failure of corneal grafts. Methods This retrospective consecutive clinical case series enrolled all cases at Qingdao Eye Hospital, Shandong Eye Institute, between January 2010 and December 2018. Causes of repeat keratoplasty, primary disease before first keratoplasty, surgical methods of the first and repeat keratoplasty, and postoperative complications were analyzed. Statistical analysis was performed using SPSS 22.0 software. Results A total of 2,060 corneal transplants was performed in our hospital, of which 228(11.07%)were repeat keratoplasties. From 2010 to 2018, repeat keratoplasties were performed in 207 eyes of 204(137 male and 67 female)patients-189 eyes with first repeat keratoplasties, 15 eyes with second repeat keratoplasties, and 3 eyes with third repeat keratoplasties. The patient age was 11 to 81(mean: 49.93±14.32)years. The main reasons for repeat keratoplasty were graft ulcers(60 cases, 26.32%), corneal graft endothelial decompensation(58 cases, 25.44%), recurrence of primary disease(41 cases, 17.98%), and graft opacity(32 cases, 14.04%). First keratoplasty was most commonly performed for purulent keratitis(69 eyes, 33.33%), followed by herpes simplex keratitis(32 eyes, 15.46%), corneal burns(22 eyes, 10.63%), and corneal dystrophy and degeneration(21 eyes, 10.14%). Penetrating keratoplasty was performed in 202 cases(88.60%)for repeat corneal transplantation, anterior lamellar keratoplasty was performed in 26 cases(11.40%), and endothelial transplantation was performed in 0 cases. There was a correlation between repeat keratoplasty and previous keratoplasty(continuous correction χ2=43.365, P<0.01). Previous surgery affects the operation of repeat keratoplasties. Infectious keratopathy(P=0.005), graft diameter >8.75 mm(P=0.040), postoperative secondary glaucoma(P=0.027), and corneal graft rejection(P=0.047)were risk factors for penetrating keratoplasty graft failure. In multivariate Cox regression analysis, infectious keratopathy(P=0.011)and graft diameter >8.75 mm(P=0.016)were risk factors for anterior lamellar keratoplasty graft failure. Conclusion The most common cause of repeat keratoplasty was corneal graft ulcer, followed by corneal graft endothelial decompensation, and recurrence of the primary disease. Infectious keratitis was the most common primary disease before the first keratoplasty, followed by herpes simplex keratitis and corneal burns. Previous surgery affects the operation of repeat keratoplasties. Infectious keratopathy, graft diameter >8.75 mm, postoperative secondary glaucoma, and corneal graft rejection were risk factors for penetrating keratoplasty graft failure, whereas infectious keratopathy and graft diameter >8.75 mm were risk factors for anterior lamellar keratoplasty graft failure.

Key words: Repeat keratoplasty, Etiology, Graft survival, Risk factors

中图分类号: 

  • R779.65
[1] Tan DTH, Dart JKG, Holland EJ, et al. Corneal transplantation[J]. The Lancet, 2012, 379(9827): 1749-1761.doi:10.1016/S0140-6736(12)60437-1.
[2] Moffatt SL, Cartwright VA, Stumpf TH. Centennial review of corneal transplantation[J]. Clinical Experimental Ophthalmology, 2005, 33(6): 642-657. doi:10.1111/j.1442-9071.2005.01134.x.
[3] Patel NP, Kim T, Rapuano CJ, et al. Indications for and outcomes of repeat penetrating keratoplasty, 1989-1995[J]. Ophthalmology, 2000, 107(4): 719-724. doi:10.1016/s0161-6420(00)00003-8.
[4] Al-Mezaine H, Wagoner MD, King Khaled Eye Specialist Hospital Cornea Transplant Study Group. Repeat penetrating keratoplasty: indications, graft survival, and visual outcome[J]. Br J Ophthalmol, 2006, 90(3): 324-327. doi:10.1136/bjo.2005.079624.
[5] 高华, 曲利军, 张菊, 等. 再次穿透性角膜移植原因临床分析[J]. 中华移植杂志(电子版), 2009, 3(3): 195-199. doi:10.3969/j.issn.1674-3903.2009.03.006. GAO Hua, QU Lijun, ZHANG Ju, et al. Etiology for repeat penetrating keratoplasty[J]. Chinese Journal of Transplanation(Electronic Edition), 2009, 3(3): 195-199. doi:10.3969/j.issn.1674-3903.2009.03.006.
[6] 陈丽, 陆佳骏, 盛敏杰, 等. 角膜保存方法现状及进展[J]. 国际眼科杂志, 2017, 17(6): 1060-1062. doi:10.3980/j.issn.1672-5123.2017.6.12. CHEN Li, LU Jiajun, SHENG Minjie, et al. Current status and progress of corneal preservation methods[J]. International Eye Science, 2017, 17(6): 1060-1062. doi:10.3980/j.issn.1672-5123.2017.6.12.
[7] Kitazawa K, Wakimasu K, Kayukawa K, et al. Moderately long-term safety and efficacy of repeat penetrating keratoplasty[J]. Cornea, 2018, 37(10): 1255-1259. doi:10.1097/ICO.0000000000001694.
[8] Srujana D, Kaur M, Urkude J, et al. Long-term functional and anatomic outcomes of repeat graft after optically failed therapeutic keratoplasty[J]. Am J Ophthalmol, 2018, 189: 166-175. doi:10.1016/j.ajo.2018.03.011.
[9] Park CY, Lee JK, Gore PK, et al. Keratoplasty in the United States: a 10-year review from 2005 through 2014[J]. Ophthalmology, 2015, 122(12): 2432-2442. doi:10.1016/j.ophtha.2015.08.017.
[10] Zhang AQ, Rubenstein D, Price AJ, et al. Evolving surgical techniques of and indications for corneal transplantation in Ontario: 2000-2012[J]. Canadian Journal of Ophthalmology, 2013, 48(3): 153-159.doi:10.1016/j.jcjo.2012.12.008.
[11] Keenan TDL, Jones MNA, Rushton S, et al. Trends in the indications for corneal graft surgery in the United Kingdom: 1999 through 2009[J]. Archives of ophthalmology, 2012, 130(5): 621-628. doi:10.1001/archophthalmol.2011.2585.
[12] 孙晓彤, 翟华蕾, 白曜, 等. 青岛某医院穿透性角膜移植手术原因[J]. 中华眼视光学与视觉科学杂志, 2019, 21(5): 375-381. doi:10.3760/cma.j.issn.1674-845X.2019.05.010. SUN Xiaotong, ZHAI Hualei, BAI Yao, et al. Analysis of causes for penetrating keratoplasty in a hospital in Qingdao[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2019, 21(5): 375-381. doi:10.3760/cma.j.issn.1674-845X.2019.05.010.
[13] Muller LJ, Marfurt CF, Kruse FE, et al. Corneal nerves: structure, contents and function[J]. Exp Eye Res, 2003, 76(5): 521-542. doi:10.1016/S0014-4835(03)00050-2.
[14] Darwish T, Brahma A, Efron N, et al. Subbasal nerve regeneration after penetrating keratoplasty[J]. Cornea, 2007, 26(8): 935-940. doi:10.1097/ICO.0b013e318-0de493f.
[15] Galletti JG, Guzmán M, Giordano MN. Mucosal immune tolerance at the ocular surface in health and disease[J]. Immunology, 2017,150(4):397-407. doi: 10.1111/imm.12716.
[16] 阳雪, 李莹. 干眼对角膜内皮细胞的影响及相关因素分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 72-76. doi:10.6040/j.issn.1673-3770.0.2018.151. YANG Xue, LI Ying. Impact of dry eye on corneal endothelial cell density and morphology[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(4): 72-76. doi:10.6040/j.issn.1673-3770.0.2018.151.
[17] 宫华青, 高华, 谢立信, 等. 穿透性角膜移植术后慢性失功移植片的超微结构观察[J]. 中华眼科杂志, 2007(4): 307-312. doi:10.3760/j.issn:0412-4081.2007.04.005. GONG Huaqing, GAO Hua, XIE Lixin, et al. Ultrastructure changes in chronic corneal ailograft dysfunction after penetrating keratoplasty[J]. Chinese Journal of Ophthalmology, 2007(4): 307-312. doi:10.3760/j.issn:0412-4081.2007.04.005.
[18] Shinomiya K, Ueta M, Sotozono C, et al. Immunohistochemical analysis of inflammatory limbal conjunctiva adjacent to Mooren's ulcer[J]. Br J Ophthalmol, 2013, 97(3): 362-366. doi:10.1136/bjophthalmol-2012-302631.
[19] Alhassan MB, Rabiu M, Agbabiaka IO. Interventions for Mooren's ulcer[J]. Cochrane Database Syst Rev,2014,22(1):CD006131. doi: 10.1002/14651858.
[20] Chen J, Xie H, Wang Z, et al. Mooren's ulcer in China: a study of clinical characteristics and treatment[J]. Br J Ophthalmol, 2000, 84(11): 1244-1249. doi:10.1136/bjo.84.11.1244.
[21] Huang T, Wang YJ, Ji JP, et al. Lamellar keratoplasty for treatment of peripheral corneal perforation[J]. Chinese Journal of Ophthalmology, 2008, 44(2): 104-110.
[22] Liu JC, Shi WY, Li SX, et al. Modified lamellar keratoplasty and immunosuppressive therapy guided by in vivo confocal microscopy for perforated Mooren's ulcer[J]. Br J Ophthalmol, 2015, 99(6): 778-783. doi:10.1136/bjophthalmol-2014-306012.
[23] Bersudsky V, Blum-Hareuveni T, Rehany U, et al. The profile of repeated corneal transplantation[J]. Ophthalmology, 2001, 108(3): 461-469. doi:10.1016/s0161-6420(00)00544-3.
[24] Ramamurthy S, Reddy JC, Vaddavalli PK, et al. Outcomes of repeat keratoplasty for failed therapeutic keratoplasty[J]. Am J Ophthalmol, 2016, 162: 83-88.e2. doi:10.1016/j.ajo.2015.11.004.
[25] Skeens HM, Holland EJ. Large-diameter penetrating keratoplasty: indications and outcomes[J]. Cornea, 2010, 29(3): 296-301. doi:10.1097/ICO.0b013e3181b6489e.
[26] Ramamurthy S, Reddy JC, Vaddavalli PK, et al. Outcomes of repeat keratoplasty for failed therapeutic keratoplasty[J]. Am J Ophthalmol, 2016, 162: 83-88.e2. doi:10.1016/j.ajo.2015.11.004.
[27] Claesson M, Armitage WJ. Ten-year follow-up of graft survival and visual outcome after penetrating keratoplasty in Sweden[J]. Cornea, 2009, 28(10): 1124-1129. doi:10.1097/ICO.0b013e3181a2a7a6.
[28] Anshu A, Lim LS, Htoon HM, et al. Postoperative risk factors influencing corneal graft survival in the Singapore Corneal Transplant Study[J]. Am J Ophthalmol, 2011, 151(3): 442-448.e1. doi:10.1016/j.ajo.2010.09.002.
[29] Tandon A, Espandar L, Cupp D, et al. Surgical management for postkeratoplasty glaucoma: a meta-analysis[J]. J Glaucoma, 2014, 23(7): 424-429. doi:10.1097/IJG.0b013e31827a0712.
[30] Kusakabe A, Okumura N, Wakimasu K, et al. Effect of trabeculotomy on corneal endothelial cell loss in cases of after penetrating-keratoplasty Glaucoma[J]. Cornea, 2017, 36(3): 317-321. doi:10.1097/ICO.0000000000-001088.
[1] 王焕霞,王淑雅,王影,孙璇,黄杰,王兴荣. 孔源性视网膜脱离玻璃体切除术后继发黄斑前膜的危险因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 181-185.
[2] 石金莲,李建兴,黄幼生,林铭轩,刘灵云,卢永田. 喉部炎性肌纤维母细胞瘤的研究现状与诊疗进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 186-192.
[3] 周之航,刘素茹,周静,陈丹,杨佳静,刘蕊,周立. 声门闭合不全的病因及诊疗研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 97-103.
[4] 潘佳煜,张春林. 急性低频感音神经性听力下降病因及发病机制的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 126-131.
[5] 李志成,闫亚,戴梁平,应俊杰, 王仁忠. 嗅觉障碍小鼠和大鼠模型的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 158-167.
[6] 彭宇婷,李坚昊,王燕. 鼻-眼眶-颅底恶性肿瘤继发眶尖综合征1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 105-111.
[7] 张琳,辛运超,尚小领,解琪,刘亚超. cN0期甲状腺微小乳头状癌颈部中央区及侧颈区淋巴结转移率、危险因素及清扫策略的临床研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 62-69.
[8] 孟素坤,张纯. 小梁消融术治疗开角型青光眼患者的长期视野缺损研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 139-148.
[9] 李璐,赵杰,赵博军. 中心性浆液性脉络膜视网膜病变的发病机制与治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 118-124.
[10] 李智林,郑洲,安韡. 12例原发性甲状腺鳞状细胞癌的临床及生存分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(1): 59-63.
[11] 肖富亮,林云,潘新良. 早期cN0 PTC预防性中央区淋巴结清扫的临床研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(1): 64-71.
[12] 李爱军,崔小梅. 白内障术前房颤人群综合路径管理现状横断面调查[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 38-44.
[13] 王兴鑫,杨欣雨,郑晓军,丁麟,盛亚文,毕晓云,杨继国. 穴位贴敷疗法治疗小儿腺样体肥大1例[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 122-124.
[14] 张礼俊, 胥然, 罗继芳, 刘国旗, 何千, 李玮, 蒋振华. 头颈肿瘤游离皮瓣修复术后皮瓣坏死及皮瓣相关并发症影响因素分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 86-90.
[15] 刘珊珊, 韩书婧, 王晓旭, 李艳红, 倪鑫, 张杰. 儿童细菌性脑膜炎后听力损害危险因素的系统评价与Meta分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 48-54.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发